US Head, Business Development & Licensing Specialty Pharma, Boehringer Ingelheim Pharmaceuticals, Inc.
Dr. Ioannis Sapountzis has over 15 year experience in the pharmaceutical industry with specific expertise in drug discovery and business development in Oncology. Ioannis is currently serving as the Global Head of Business Development & Licensing for the USA & Specialty Care at Boehringer Ingelheim Pharmaceuticals, Inc. Previously, he was Boehringer’s Global Head of Oncology Business Development & Licensing. Ioannis joined Boehringer Ingelheim in 2005 as a medicinal chemist and project leader in the Oncology therapeutic area, and later transitioned to strategic roles in the Corporate Department of Research Networking.
Ioannis holds a PhD in organic chemistry from the Ludwig Maximilians University in Munich, Germany, and did his postdoctoral fellowship with David Evans at Harvard University working on total synthesis of antibiotics.